← Back to Search

Energy Delivery Device

Active for Osteopenia

N/A
Waitlist Available
Led By Laura Bilek, PT, PhD
Research Sponsored by Theranova, L.L.C.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months

Summary

This trial tests the Spry Belt, a hip-worn device that sends energy to bones, on postmenopausal women with low bone mass. The goal is to see if it can improve bone quality by stimulating bone cells and reducing bone loss.

Eligible Conditions
  • Osteopenia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of device-related adverse events present
Vertebral body strength
Secondary study objectives
Femoral bone mineral density
Vertebral body bone mineral density

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ActiveExperimental Treatment1 Intervention
Subjects in this group will receive the active treatment for each daily treatment session.
Group II: ShamPlacebo Group1 Intervention
Subjects in this group will receive the sham treatment for each daily treatment session.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spry Belt
2022
N/A
~100

Find a Location

Who is running the clinical trial?

Theranova, L.L.C.Lead Sponsor
12 Previous Clinical Trials
369 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,782 Previous Clinical Trials
28,183,953 Total Patients Enrolled
University of NebraskaOTHER
555 Previous Clinical Trials
1,145,224 Total Patients Enrolled
~23 spots leftby Nov 2025